Aurinia Pharmaceuticals Inc.
US ˙ NasdaqGM ˙ CA05156V1022

SecurityAUPH / Aurinia Pharmaceuticals Inc.
InstitutionWolverine Trading, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Wolverine Trading, Llc ownership in AUPH / Aurinia Pharmaceuticals Inc.

On August 18, 2025 - Wolverine Trading, Llc filed a 13F-HR form disclosing ownership of 0 shares of Aurinia Pharmaceuticals Inc. (US:AUPH) valued at $0 USD as of June 30, 2025. The entity filed a previous 13F-HR on May 15, 2025 disclosing 19,374 shares of Aurinia Pharmaceuticals Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Wolverine Trading, Llc has a history of taking positions in derivatives of the underlying security (AUPH) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AUPH / Aurinia Pharmaceuticals Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-18 2025-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 0 -19,374 -100.00 0 -100.00
2025-05-15 2025-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 19,374 19,374 161 0.0002
2025-02-14 2024-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 0 -206,099 -100.00 0 -100.00
2024-11-14 2024-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 206,099 206,099 1,500 0.0016
2023-11-15 2023-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 0 -13,220 -100.00 0 -100.00
2023-08-23 2023-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 13,220 13,220 121 0.0001
2022-08-15 2022-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 0 -52,074 -100.00 0 -100.00
2022-05-16 2022-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 52,074 -2,523 -4.62 645 -48.15 0.0008
2022-02-14 2021-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 54,597 8,279 17.87 1,244 16.81 0.0015
2021-11-12 2021-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 46,318 46,318 1,065 0.0012
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F AURINIA PHARMACEUTICALS COM Call 0 -100.00 0 n/a n/a n/a
2025-08-18 2025-06-30 13F AURINIA PHARMACEUTICALS COM Call 80,600 -4.16 696 -0.14 n/a n/a n/a
2025-05-15 2025-03-31 13F AURINIA PHARMACEUTICALS COM Call 84,100 -16.65 697 -24.65 n/a n/a n/a
2025-02-14 2024-12-31 13F AURINIA PHARMACEUTICALS COM Call 100,900 22.90 925 54.94 n/a n/a n/a
2024-11-14 2024-09-30 13F AURINIA PHARMACEUTICALS COM Call 82,100 598 n/a n/a n/a
2024-08-14 2024-06-30 13F AURINIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F AURINIA PHARMACEUTICALS COM Call 79,700 -57.54 399 -76.35 n/a n/a n/a
2024-02-14 2023-12-31 13F AURINIA PHARMACEUTICALS COM Call 187,700 1,687 n/a n/a n/a
2023-11-15 2023-09-30 13F AURINIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-23 2023-06-30 13F AURINIA PHARMACEUTICALS COM Call 160,300 -5.48 1,468 146,700.00 n/a n/a n/a
2023-05-15 2023-03-31 13F AURINIA PHARMACEUTICALS COM Call 169,600 16.97 2 -99.84 n/a n/a n/a
2023-02-14 2022-12-31 13F AURINIA PHARMACEUTICALS COM Call 145,000 626 n/a n/a n/a
2022-08-15 2022-06-30 13F AURINIA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-16 2022-03-31 13F AURINIA PHARMACEUTICALS COM Call 180,000 -1.15 2,230 -46.24 n/a n/a n/a
2022-02-14 2021-12-31 13F AURINIA PHARMACEUTICALS COM Call 182,100 -1.94 4,148 -2.83 n/a n/a n/a
2021-11-12 2021-09-30 13F AURINIA PHARMACEUTICALS COM Call 185,700 4,269 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F AURINIA PHARMACEUTICALS COM Put 0 -100.00 0 n/a n/a n/a
2025-08-18 2025-06-30 13F AURINIA PHARMACEUTICALS COM Put 26,000 4.42 225 8.74 n/a n/a n/a
2025-05-15 2025-03-31 13F AURINIA PHARMACEUTICALS COM Put 24,900 -16.72 206 -24.82 n/a n/a n/a
2025-02-14 2024-12-31 13F AURINIA PHARMACEUTICALS COM Put 29,900 -5.68 274 19.13 n/a n/a n/a
2024-11-14 2024-09-30 13F AURINIA PHARMACEUTICALS COM Put 31,700 231 n/a n/a n/a
2024-08-14 2024-06-30 13F AURINIA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F AURINIA PHARMACEUTICALS COM Put 21,800 -68.54 109 -82.50 n/a n/a n/a
2024-02-14 2023-12-31 13F AURINIA PHARMACEUTICALS COM Put 69,300 623 n/a n/a n/a
2023-11-15 2023-09-30 13F AURINIA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-23 2023-06-30 13F AURINIA PHARMACEUTICALS COM Put 116,400 49.42 1,066 n/a n/a n/a
2023-05-15 2023-03-31 13F AURINIA PHARMACEUTICALS COM Put 77,900 429.93 1 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F AURINIA PHARMACEUTICALS COM Put 14,700 64 n/a n/a n/a
2022-08-15 2022-06-30 13F AURINIA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-16 2022-03-31 13F AURINIA PHARMACEUTICALS COM Put 108,100 23.12 1,339 -33.05 n/a n/a n/a
2022-02-14 2021-12-31 13F AURINIA PHARMACEUTICALS COM Put 87,800 -20.90 2,000 -21.63 n/a n/a n/a
2021-11-12 2021-09-30 13F AURINIA PHARMACEUTICALS COM Put 111,000 2,552 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.